Skip to content
Search AI Powered

Latest Stories

Sajid Javid lauds community pharmacy for doing an ‘amazing job’ over the entire pandemic

Health secretary Sajid Javid has acknowledged and appreciated the hard work done by community pharmacies in serving people during the Covid-19 pandemic.

“Community pharmacies have done an absolutely amazing job over the entire pandemic right from day one,” he said, on the sidelines of a roundtable held at the Department of Health and Social Care in central London on September 28.


“They were on the frontline, they stayed open when many other businesses, we understand, had to be closed, because they're more than a business. They are part of your community serving critical needs.”

He added that during the pandemic, community pharmacies stepped up to deliver more than their routine services, by providing additional care in several ways and advising the country that was in a state of shock at the start of the crisis.

Javid said: “We didn't have the answer. So first of all, I can't thank community pharmacists enough for what they've been doing throughout the pandemic – when it comes to helping with vaccination programme, or in other ways.

“We absolutely need to make sure that they're getting the support that they need. We constantly keep it under review.”

Meetings with sector leaders

Health secretary Javid informed that he often meets with community pharmacy leaders to discuss their needs.

“I think that dialogue is important to make sure that we're listening and doing everything.”

Talking about the success of Covid vaccination drive in the country, he said: “Britain has been a leader in vaccine uptake. But it's been uneven.”

The national vaccination data shows the uptake of more than 80 per cent for a double dose, but a community-based segregation shows a different picture.

Vaccine uptake

Vaccination uptake amongst the British Indian community stands at 70 per cent, and for the British Pakistani community, it's about 55 per cent.

Javid said: “It has improved a lot in the last couple of months. But I wanted to certainly encourage more people to take up the offered vaccine, if you're eligible. Please take it because we know it saves lives when it protects those people around you, and not just those who are taking the vaccine.”

He added that all medical organisations including the British Medical Association agree on this that “the vaccine works.”

“There are 200,000 or fewer people in hospital because of the vaccines, there are 126,000 fewer deaths because of the vaccines and that really has got to be a central message.

To be able to say goodbye to this pandemic at some point in the future “we just need more people to take up the vaccine if it is offered to them.”

More For You

Sigma Conference: "Pharmacists need greater role in integrated care boards," says CPE representative

Prakash Patel was speaking at a panel discussion at the Sigma Conference

Sigma Conference: "Pharmacists need greater role in integrated care boards," says CPE representative

Pharmacists need to be a part of integrated care boards (ICB) to stop GPs from monopolising services based on their needs rather than the needs of the patient, according to Prakash Patel, Community Pharmacy Engaland (CPE) representative for North London.

“The evolution of the NHS should mean there can be no decision of pharmacy without pharmacist,” Patel told delegates at the Sigma Pharmacy Conference in Baku, Azerbaijan on Tuesday.

Keep ReadingShow less
David Webb
David Webb, NHS England's Chief Pharmaceutical Officer
David Webb, NHS England's Chief Pharmaceutical Officer

Sigma Conference: "Community pharmacy ready to make a profound contribution to 10 Year Health Plan," says David Webb

A national community pharmacy prescribing service remains a long-term goal of the government, according to NHS chief pharmaceutical officer, David Webb.

The Labour Party in its election manifesto last year said it would “create a Community Pharmacist Prescribing Service, granting more pharmacists independent prescribing rights”.

Keep ReadingShow less
New professional liability insurance policy for RPS members launched

The insurance will be provided to members at cost, with no profit made by RPS.

gettyimages

RPS launches professional liability insurance for members

The Royal Pharmaceutical Society (RPS) has launched a new professional liability insurance policy, designed to empower pharmacists to work confidently and deliver high-quality care, knowing they are protected.

Exclusively available to its members, the comprehensive and affordable insurance has been developed in collaboration with global professional services firm Aon.

Keep ReadingShow less
Cargo plane unloading pharmaceuticals at US airport amid tariff concerns and stockpiling

Imports jumped in particular from Ireland, the top drug exporter to the US

Pic credit: iStock

Pharma imports to US surged in March as drugmakers look to avoid tariffs

Pharmaceutical imports to the US surged in March as drugmakers stocked up ahead of potential US tariffs on their products, which have historically been exempt from such fees.

Total imports of pharmaceutical products exceeded $50 billion in the month - the equivalent of 20 per cent of all pharmaceutical imports in 2024, according to data from a U.S. Commerce Department report on Tuesday.

Keep ReadingShow less
Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less